FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

782371005: Galcanezumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3753680011 Galcanezumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3753681010 Galcanezumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3753680011 Galcanezumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3753681010 Galcanezumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5589921000241117 galcanézumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
5589921000241117 galcanézumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Galcanezumab (substance) Has disposition Calcitonin gene-related peptide receptor antagonist true Inferred relationship Existential restriction modifier (core metadata concept)
Galcanezumab (substance) Is a Monoclonal antibody true Inferred relationship Existential restriction modifier (core metadata concept)
Galcanezumab (substance) Is a Substance with calcitonin gene-related peptide receptor antagonist mechanism of action (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing only galcanezumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Galcanezumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Galcanezumab-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Galcanezumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing galcanezumab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Galcanezumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Galcanezumab only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Galcanezumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Galcanezumab 120 mg/mL solution for injection Has precise active ingredient True Galcanezumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Galcanezumab 120 mg/mL solution for injection Has basis of strength substance (attribute) True Galcanezumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start